Skip to main content
Top
Published in: Supportive Care in Cancer 8/2010

01-08-2010 | Original Article

Psychological well-being in a cohort of women with invasive breast cancer nearly 2 years after diagnosis

Authors: Robin J. Bell, Marijana Lijovic, Maria La China, Max Schwarz, Pamela Fradkin, Jo Bradbury, Susan R. Davis

Published in: Supportive Care in Cancer | Issue 8/2010

Login to get access

Abstract

Purpose

The aim of this study was to document the psychological well-being of a group of women with invasive breast cancer (BC) on an average of nearly 2 years after their diagnosis.

Methods

Participants were women in the Medical Benefits Fund Australia Limited Foundation Health and Wellbeing after Breast Cancer Study, a cohort study of 1,684 women recruited within 12 months of their diagnosis with invasive BC, who completed their first annual follow-up questionnaire. Psychological well-being was measured using the Psychological General Well Being Index questionnaire (PGWB) in women with BC.

Results

The PGWB questionnaire was completed by 1,589 women on an average of 92 weeks after their BC diagnosis, of whom 46 had evidence of active disease. PGWB total scores for all age groups of the BC cohort were lower than community-based norms (p < 0.001 for age groups ≥70, 60–<70, 50–60; p = 0.002 for age group 40–<50 and p = 0.05 for age group <40). PGWB total scores for the BC cohort were positively associated with age (p < 0.001) and living with others (p < 0.01) and inversely associated with active disease (p < 0.001) and education beyond secondary school (p = 0.03). For the domain of anxiety, there was no statistically significant association with living with others but an inverse association with education beyond school.

Conclusion

A higher level of education may be associated with increased anxiety and lower well-being. Social support is particularly important for women with BC who are known to live alone.
Literature
1.
go back to reference Centers for Disease control and Prevention (CDC) (2004) Cancer survivorship—United States, 1971–2001. Morb Mortal Wkly Rep (MMWR) 53(24):526–529 Centers for Disease control and Prevention (CDC) (2004) Cancer survivorship—United States, 1971–2001. Morb Mortal Wkly Rep (MMWR) 53(24):526–529
2.
go back to reference Stanton AL, Ganz PA, Rowland JH, Meyerowitz BE, Krupnick JL, Sears SR (2005) Promoting adjustment after treatment for cancer. Cancer 104:2608–2613CrossRefPubMed Stanton AL, Ganz PA, Rowland JH, Meyerowitz BE, Krupnick JL, Sears SR (2005) Promoting adjustment after treatment for cancer. Cancer 104:2608–2613CrossRefPubMed
3.
go back to reference Ganz PA, Casillas J, Hahn EE (2008) Ensuring quality care for cancer survivors: implementing the survivorship care plan. Sem Oncol Nurs 24:208–217CrossRef Ganz PA, Casillas J, Hahn EE (2008) Ensuring quality care for cancer survivors: implementing the survivorship care plan. Sem Oncol Nurs 24:208–217CrossRef
4.
go back to reference Andrykowski MA, Lykins E, Floyd A (2008) Psychological health in cancer survivors. Sem Oncol Nurs 24:193–201CrossRef Andrykowski MA, Lykins E, Floyd A (2008) Psychological health in cancer survivors. Sem Oncol Nurs 24:193–201CrossRef
5.
go back to reference Ferrell BR, Dow KH, Grant M (1995) Measurement of the quality of life in cancer survivors. Qual Life Res 4:523–531CrossRefPubMed Ferrell BR, Dow KH, Grant M (1995) Measurement of the quality of life in cancer survivors. Qual Life Res 4:523–531CrossRefPubMed
6.
go back to reference Crespi CM, Ganz PA, Petersen L, Castillo A, Caan B (2008) Refinement and psychometric evaluation of the impact of cancer scale. J Natl Cancer Inst 100:1530–1541CrossRefPubMed Crespi CM, Ganz PA, Petersen L, Castillo A, Caan B (2008) Refinement and psychometric evaluation of the impact of cancer scale. J Natl Cancer Inst 100:1530–1541CrossRefPubMed
7.
go back to reference Lijovic M, Davis SR, Fradkin P, La China M, Farrugia H, Wolfe R, Bell RJ (2008) Use of a cancer registry is preferable to a direct-to-community approach for recruitment to a cohort study of wellbeing in women newly diagnosed with invasive breast cancer. BMC cancer 8:126CrossRefPubMed Lijovic M, Davis SR, Fradkin P, La China M, Farrugia H, Wolfe R, Bell RJ (2008) Use of a cancer registry is preferable to a direct-to-community approach for recruitment to a cohort study of wellbeing in women newly diagnosed with invasive breast cancer. BMC cancer 8:126CrossRefPubMed
8.
go back to reference Dupuy H (1984) The psychological general well-being (PGWB) index. In: Wenger NMM, Furberg C, Elinson J (eds) Assessment of quality of life in clinical trials of cardiovascular therapies. Le Jacq Publishing, New York, pp 170–183 Dupuy H (1984) The psychological general well-being (PGWB) index. In: Wenger NMM, Furberg C, Elinson J (eds) Assessment of quality of life in clinical trials of cardiovascular therapies. Le Jacq Publishing, New York, pp 170–183
9.
go back to reference Davison SL, Bell R, Donath S, Montalto JG, Davis SR (2005) Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 90:3847–3853CrossRefPubMed Davison SL, Bell R, Donath S, Montalto JG, Davis SR (2005) Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 90:3847–3853CrossRefPubMed
10.
go back to reference Bell RJ, Donath S, Davison SL, Davis SR (2006) Endogenous androgen levels and well-being: differences between premenopausal and postmenopausal women. Menopause (New York, NY) 13:65–71 Bell RJ, Donath S, Davison SL, Davis SR (2006) Endogenous androgen levels and well-being: differences between premenopausal and postmenopausal women. Menopause (New York, NY) 13:65–71
11.
go back to reference Australian Bureau of Statistics (1997) SF-36 Population Norms 1995. Canberra, Australia pp 1–38 Australian Bureau of Statistics (1997) SF-36 Population Norms 1995. Canberra, Australia pp 1–38
12.
go back to reference Bell RJ, Lijovic M, Fradkin P, Bradbury J, La China M, Schwarz M, Wolfe R, Farrugia H, Davis SR (2009) Lack of knowledge of hormone receptor status is associated with lower prevalence of use of endocrine therapy in women with invasive breast cancer. Journal of Women's Health (in press) Bell RJ, Lijovic M, Fradkin P, Bradbury J, La China M, Schwarz M, Wolfe R, Farrugia H, Davis SR (2009) Lack of knowledge of hormone receptor status is associated with lower prevalence of use of endocrine therapy in women with invasive breast cancer. Journal of Women's Health (in press)
13.
go back to reference Urquhart DM, Shortreed S, Davis SR, Cicuttini FM, Bell RJ (2009) Are low levels of low back pain intensity and disability associated with reduced well-being in community-based women? Climacteric 12:266–275CrossRefPubMed Urquhart DM, Shortreed S, Davis SR, Cicuttini FM, Bell RJ (2009) Are low levels of low back pain intensity and disability associated with reduced well-being in community-based women? Climacteric 12:266–275CrossRefPubMed
14.
go back to reference Mukherjee A, Tolhurst-Cleaver S, Ryder WD, Smethurst L, Shalet SM (2005) The characteristics of quality of life impairment in adult growth hormone (GH)-deficient survivors of cancer and their response to GH replacement therapy. J Clin Endocrinol Metab 90:1542–1549CrossRefPubMed Mukherjee A, Tolhurst-Cleaver S, Ryder WD, Smethurst L, Shalet SM (2005) The characteristics of quality of life impairment in adult growth hormone (GH)-deficient survivors of cancer and their response to GH replacement therapy. J Clin Endocrinol Metab 90:1542–1549CrossRefPubMed
15.
go back to reference Baker F, Denniston M, Smith T, West MM (2005) Adult cancer survivors: how are they faring? Cancer 104:2565–2576CrossRefPubMed Baker F, Denniston M, Smith T, West MM (2005) Adult cancer survivors: how are they faring? Cancer 104:2565–2576CrossRefPubMed
16.
go back to reference Ganz PA, Greendale GA, Petersen L, Kahn B, Bower JE (2003) Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol 21:4184–4193CrossRefPubMed Ganz PA, Greendale GA, Petersen L, Kahn B, Bower JE (2003) Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol 21:4184–4193CrossRefPubMed
17.
go back to reference Zebrack BJ, Yi J, Petersen L, Ganz PA (2008) The impact of cancer and quality of life for long-term survivors. Psycho-oncol 17:891–900CrossRef Zebrack BJ, Yi J, Petersen L, Ganz PA (2008) The impact of cancer and quality of life for long-term survivors. Psycho-oncol 17:891–900CrossRef
18.
go back to reference Gudbergsson SB, Fossa SD, Ganz PA, Zebrack BJ, Dahl AA (2007) The associations between living conditions, demography, and the 'impact of cancer' scale in tumor-free cancer survivors: a NOCWO study. Support Care Cancer 15:1309–1318CrossRefPubMed Gudbergsson SB, Fossa SD, Ganz PA, Zebrack BJ, Dahl AA (2007) The associations between living conditions, demography, and the 'impact of cancer' scale in tumor-free cancer survivors: a NOCWO study. Support Care Cancer 15:1309–1318CrossRefPubMed
19.
go back to reference Marmot M (2002) The influence of income on health: views of an epidemiologist. Health Aff (Project Hope) 21:31–46CrossRef Marmot M (2002) The influence of income on health: views of an epidemiologist. Health Aff (Project Hope) 21:31–46CrossRef
20.
go back to reference Vivar CG, McQueen A (2005) Informational and emotional needs of long-term survivors of breast cancer. J Adv Nurs 51:520–528CrossRefPubMed Vivar CG, McQueen A (2005) Informational and emotional needs of long-term survivors of breast cancer. J Adv Nurs 51:520–528CrossRefPubMed
Metadata
Title
Psychological well-being in a cohort of women with invasive breast cancer nearly 2 years after diagnosis
Authors
Robin J. Bell
Marijana Lijovic
Maria La China
Max Schwarz
Pamela Fradkin
Jo Bradbury
Susan R. Davis
Publication date
01-08-2010
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 8/2010
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-009-0726-z

Other articles of this Issue 8/2010

Supportive Care in Cancer 8/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine